During the past decade, NZOZ Centrum Medyczne HCP Sp. z o.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Centrum Medyczne HCP Sp. z o.o." #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Cardiac Dimensions, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Centrum Medyczne HCP Sp. z o.o." #1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Centrum Medyczne HCP Sp. z o.o." are "Ulcerative Colitis" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Bipolar I Disorder" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "NZOZ Centrum Medyczne HCP Sp. z o.o." in a lesser frequency.

Most popular intervention types in "NZOZ Centrum Medyczne HCP Sp. z o.o." are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5-Fluorouracil" (2 trials), "Pertuzumab" (2 trials), "225mg SHP647 (PF-00547659)" (1 trials) and "75mg SHP647 (PF-00547659)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Centrum Medyczne HCP Sp. z o.o." are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NZOZ Centrum Medyczne HCP Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in NZOZ Centrum Medyczne HCP Sp. z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Centrum Medyczne HCP Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".